Location History:
- Encinitas, CA (US) (2018 - 2023)
- San Marcos, CA (US) (2023)
Company Filing History:
Years Active: 2018-2025
Title: Jerry Mozoruk: Innovator in Gene Modification Technologies
Introduction
Jerry Mozoruk is a notable inventor based in Encinitas, California, recognized for his contributions to the field of genetic engineering. With a total of eight patents to his name, he has focused on enhancing the efficiency of targeted gene modification techniques, which have significant implications for agriculture and biotechnology.
Latest Patents
Among Mozoruk's latest innovations are two key patents related to methods and compositions for increasing the efficiency of targeted gene modification using oligonucleotide-mediated gene repair. These inventions improve gene modification processes in plant cells, leading to more effective mutations and genetic changes. More specifically, the patents discuss combining gene repair oligonucleotides with strategies that enhance the availability of components essential for natural gene repair mechanisms in cells. This advancement holds promise for the development of plants and seeds with desirable traits.
Career Highlights
Throughout his career, Jerry Mozoruk has made significant strides in the biotechnology sector, having worked with companies like Cibus US LLC and Cibus Europe B.V. His work has been instrumental in developing innovative solutions that address challenges in genetic modification, particularly in the agricultural sector.
Collaborations
Mozoruk’s success can be attributed in part to his collaborations with esteemed colleagues such as Peter R. Beetham and Gregory F.W. Gocal. Together, they have pushed the boundaries of genetic engineering, leveraging their combined expertise to advance the field.
Conclusion
Jerry Mozoruk's contributions to the biotechnology industry, particularly in the realm of gene modification, exemplify the power of innovation in shaping the future of agriculture. With his extensive patent portfolio and collaborative spirit, Mozoruk continues to pave the way for breakthroughs that may redefine genetic engineering practices.